查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585716

血庫市場：按類型、產品和最終用戶分類 - 全球預測 2025-2030

Blood Banking Market by Type (Private, Public), Product (Plasma, Platelets, Red Blood Cells), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血庫市值為150.1億美元，預計到2024年將達到168.9億美元，複合年成長率為12.99%，預計到2030年將達到353.1億美元。

血庫市場是醫療保健服務的重要組成部分，包括人類血液和血液成分的採集、處理、測試、儲存和分配。對血庫的需求源於其在透過輸血拯救生命、治療各種醫療狀況和緊急情況以及支持手術方面發揮的重要作用。重要的應用包括管理血液疾病、支持癌症治療和協助創傷治療。最終使用領域包括醫院、診所、血庫、門診手術中心、實驗室等。市場成長受到諸如需要輸血的慢性疾病盛行率上升、外科手術數量增加、政府為安全和可及的血液供應採取的舉措以及血液保存和儲存技術的進步等因素的影響。自動採血系統、病原體減少技術和改進的血液檢測方法等創新提供了巨大的機會。透過強調夥伴關係和合作來加強研發，相關人員可以有效地解決這些市場差距。但也存在監管政策嚴格、血液感染風險、營運成本高、血液採集和儲存方法缺乏標準化等挑戰。此外，發展中地區的意識低落也是一個主要障礙。為了利用成長機會，相關人員應優先投資行動採血技術並擴大捐血者招募策略。低溫運輸物流和血液庫存管理預測分析的創新可能會徹底改變該產業。市場本質上是動態的，由持續的需求和創新驅動，並且必須不斷適應技術進步和監管變化。透過專注於合成血液替代和人造血液的前沿研究，公司可以滿足不斷變化的需求並降低供應風險。此外，提高公眾對捐血及其挽救生命益處的認知和教育將加強我們的市場基礎，並確保穩定的血液供應鏈，以滿足不斷成長的醫療保健需求。

主要市場統計
基準年[2023] 150.1億美元
預測年份 [2024] 168.9億美元
預測年份 [2030] 353.1億美元
複合年成長率（%） 12.99%

市場動態：揭示快速發展的血庫市場的關鍵市場洞察

供需的動態交互作用正在改變血庫市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 血液病患病率高，案例數量不斷增加
    • 輸血感染疾病和手術增加導致血液傳染疾病負擔增加
    • 政府和非政府舉措，例如舉辦捐血營；
    • 愛滋病毒和B型肝炎等輸血感染疾病的盛行率很高
  • 市場限制因素
    • 維護和血液處理設備高成本
  • 市場機會
    • 對先進設備的需求增加
    • 積極改變贖回場景
    • 提高捐血和安全輸血意識
  • 市場挑戰
    • 嚴格的規章制度場景

波特五力：駕馭血庫市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解血庫市場的外部影響

外部宏觀環境因素對血站市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解血庫市場的競爭格局

血庫市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣血庫市場供應商績效評估

FPNV 定位矩陣是評估血庫市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃血庫市場的成功之路

血庫市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 血液病患病率高，事故發生率增加
      • 血液傳染疾病的負擔正在增加，同時與輸血相關的感染疾病和手術也在增加。
      • 政府和非政府舉措，例如舉辦捐血營
      • 愛滋病毒和B型肝炎等輸血傳染性行為感染的盛行率很高
    • 抑制因素
      • 維護和血液處理設備成本高昂
    • 機會
      • 對先進設備的需求增加
      • 積極改變贖回場景
      • 提高捐血和安全輸血意識
    • 任務
      • 嚴格的規章制度場景
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 血庫市場：依類型

  • 私人的
  • 公共

第7章 血庫市場：依產品

  • 電漿
  • 血小板
  • 紅血球
  • 白血球
  • 全血

第8章 血庫市場：依最終用戶分類

  • 門診手術中心
  • 診斷中心
  • 醫院

第9章美洲的血庫市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太血庫市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的血庫市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AMAG Pharmaceuticals, Inc.
  • Americord Registry LLC
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc
  • bioMerieux SA
  • Cardinal Health, Inc
  • China Biologic Products, Inc.
  • Cordlife Group Limited
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi AG
  • Immucor, Inc.
  • Johnson & Johnson
  • Krew Instruments Pvt Ltd
  • Macopharma SA
  • Narang Medical Limited
  • Remi Elektrotechnik Limited
  • Terumo BCT, Inc.
  • Thermo Fisher Scientific Inc.
  • ViaCord LLC
Product Code: MRR-434CCDA04D00

The Blood Banking Market was valued at USD 15.01 billion in 2023, expected to reach USD 16.89 billion in 2024, and is projected to grow at a CAGR of 12.99%, to USD 35.31 billion by 2030.

The blood banking market, an essential component of healthcare services, encompasses the collection, processing, testing, storage, and distribution of human blood and blood components. The necessity of blood banking arises from its critical role in saving lives through transfusions, treating various medical conditions, emergencies, and supporting surgeries. Vital applications include managing blood disorders, supporting cancer treatments, and aiding trauma care. The end-use sectors encompass hospitals, clinics, blood banks, ambulatory surgical centers, and research laboratories. Market growth is influenced by factors such as the rising prevalence of chronic diseases requiring blood transfusions, increased surgical procedures, government initiatives for safe and accessible blood supply, and advancements in blood storage and preservation techniques. Technological innovations, like automated blood collection systems, pathogen reduction technologies, and improved blood testing methods, provide significant opportunities. Emphasizing partnerships and collaborations for enhanced R&D will enable stakeholders to address these market gaps effectively. However, challenges include stringent regulatory policies, the risk of bloodborne infections, high operational costs, and a lack of standardization in blood collection and storage practices. Additionally, limited awareness in developing regions poses a significant hurdle. To capitalize on growth opportunities, stakeholders should prioritize investments in mobile blood collection technologies and expand donor recruitment strategies. Innovations in cold chain logistics and predictive analytics for blood inventory management can revolutionize the industry. The market's nature is dynamic, driven by consistent demand and innovations, requiring constant adaptation to technological advancements and regulatory changes. By focusing on cutting-edge research in synthetic blood substitutes and artificial blood, businesses can cater to evolving needs and mitigate supply risks. Additionally, enhancing public awareness and education about blood donation and its life-saving benefits can strengthen market foundations and ensure a stable blood supply chain to meet expanding healthcare demands.

KEY MARKET STATISTICS
Base Year [2023] USD 15.01 billion
Estimated Year [2024] USD 16.89 billion
Forecast Year [2030] USD 35.31 billion
CAGR (%) 12.99%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Banking Market

The Blood Banking Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of hematologic diseases and rising incidences of accidental cases
    • Growing burden of blood-borne diseases coupled with the increasing prevalence of transfusion transmissible infection and surgeries
    • Government and non-government initiatives such as conduction of blood donation camps
    • High prevalence of transfusion transmissible infections such as HIV and hepatitis B
  • Market Restraints
    • High cost of maintenance and blood processing equipment
  • Market Opportunities
    • Increasing demand for advanced instruments
    • Positively changing reimbursement scenarios
    • Growing awareness about blood donation and safe blood transfusion
  • Market Challenges
    • Stringent rules and regulations scenario

Porter's Five Forces: A Strategic Tool for Navigating the Blood Banking Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Banking Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Banking Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Banking Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Banking Market

A detailed market share analysis in the Blood Banking Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Banking Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Banking Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Banking Market

A strategic analysis of the Blood Banking Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Banking Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMAG Pharmaceuticals, Inc., Americord Registry LLC, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc, bioMerieux SA, Cardinal Health, Inc, China Biologic Products, Inc., Cordlife Group Limited, F. Hoffmann-La Roche Ltd, Fresenius Kabi AG, Immucor, Inc., Johnson & Johnson, Krew Instruments Pvt Ltd, Macopharma SA, Narang Medical Limited, Remi Elektrotechnik Limited, Terumo BCT, Inc., Thermo Fisher Scientific Inc., and ViaCord LLC.

Market Segmentation & Coverage

This research report categorizes the Blood Banking Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Private and Public.
  • Based on Product, market is studied across Plasma, Platelets, Red Blood Cells, White Blood Cells, and Whole Blood.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of hematologic diseases and rising incidences of accidental cases
      • 5.1.1.2. Growing burden of blood-borne diseases coupled with the increasing prevalence of transfusion transmissible infection and surgeries
      • 5.1.1.3. Government and non-government initiatives such as conduction of blood donation camps
      • 5.1.1.4. High prevalence of transfusion transmissible infections such as HIV and hepatitis B
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of maintenance and blood processing equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for advanced instruments
      • 5.1.3.2. Positively changing reimbursement scenarios
      • 5.1.3.3. Growing awareness about blood donation and safe blood transfusion
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent rules and regulations scenario
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Banking Market, by Type

  • 6.1. Introduction
  • 6.2. Private
  • 6.3. Public

7. Blood Banking Market, by Product

  • 7.1. Introduction
  • 7.2. Plasma
  • 7.3. Platelets
  • 7.4. Red Blood Cells
  • 7.5. White Blood Cells
  • 7.6. Whole Blood

8. Blood Banking Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostic Centers
  • 8.4. Hospitals

9. Americas Blood Banking Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Blood Banking Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Blood Banking Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AMAG Pharmaceuticals, Inc.
  • 3. Americord Registry LLC
  • 4. Beckman Coulter, Inc.
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories Inc
  • 7. bioMerieux SA
  • 8. Cardinal Health, Inc
  • 9. China Biologic Products, Inc.
  • 10. Cordlife Group Limited
  • 11. F. Hoffmann-La Roche Ltd
  • 12. Fresenius Kabi AG
  • 13. Immucor, Inc.
  • 14. Johnson & Johnson
  • 15. Krew Instruments Pvt Ltd
  • 16. Macopharma SA
  • 17. Narang Medical Limited
  • 18. Remi Elektrotechnik Limited
  • 19. Terumo BCT, Inc.
  • 20. Thermo Fisher Scientific Inc.
  • 21. ViaCord LLC

LIST OF FIGURES

  • FIGURE 1. BLOOD BANKING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD BANKING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD BANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD BANKING MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD BANKING MARKET SIZE, BY WHITE BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BLOOD BANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM BLOOD BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2023